Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Takeuchi

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
NPJ Precision Oncology|March 1, 2022
STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosisNaohiro Yanagimura, Shinji Takeuchi, Koji Fukuda, et al.
The Journal of Cell Biology|June 6, 2023
Development of ultrafast camera-based single fluorescent-molecule imaging for cell biologyTakahiro K Fujiwara, Shinji Takeuchi, Ziya Kalay, et al.
Cancer Science|February 10, 2017
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formationShinji Takeuchi, Koji Fukuda, Tadaaki Yamada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancerWei Wang, Qi Li, Shinji Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Proteasome Inhibition Overcomes ALK-TKI Resistance in <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant NSCLC via Noxa ExpressionAzusa Tanimoto, Shingo Matsumoto, Shinji Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Foretinib Overcomes Entrectinib Resistance Associated with the <i>NTRK1</i> G667C Mutation in <i>NTRK1</i> Fusion-Positive Tumor Cells in a Brain Metastasis ModelAkihiro Nishiyama, Tadaaki Yamada, Kenji Kita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 11, 2023
Successful second-line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal-epithelial transition factor amplificationMakoto Yamamoto, Takeshi Terashima, Tatsuya Yamashita, et al.
Cancer Research|November 11, 2010
Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivoShinji Takeuchi, Akiko Takahashi, Noriko Motoi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutationJunya Nakade, Shinji Takeuchi, Takayuki Nakagawa, et al.
Pancreas|July 19, 2014
Expression of Akt kinase-interacting protein 1, a scaffold protein of the PI3K/PDK1/Akt pathway, in pancreatic cancerKoushiro Ohtsubo, Tadaaki Yamada, Lu Zhao, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
NPJ Precision Oncology|March 1, 2022
STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosisNaohiro Yanagimura, Shinji Takeuchi, Koji Fukuda, et al.
The Journal of Cell Biology|June 6, 2023
Development of ultrafast camera-based single fluorescent-molecule imaging for cell biologyTakahiro K Fujiwara, Shinji Takeuchi, Ziya Kalay, et al.
Cancer Science|February 10, 2017
Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formationShinji Takeuchi, Koji Fukuda, Tadaaki Yamada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Met kinase inhibitor E7050 reverses three different mechanisms of hepatocyte growth factor-induced tyrosine kinase inhibitor resistance in EGFR mutant lung cancerWei Wang, Qi Li, Shinji Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2020
Proteasome Inhibition Overcomes ALK-TKI Resistance in <i>ALK</i>-Rearranged/<i>TP53</i>-Mutant NSCLC via Noxa ExpressionAzusa Tanimoto, Shingo Matsumoto, Shinji Takeuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2018
Foretinib Overcomes Entrectinib Resistance Associated with the <i>NTRK1</i> G667C Mutation in <i>NTRK1</i> Fusion-Positive Tumor Cells in a Brain Metastasis ModelAkihiro Nishiyama, Tadaaki Yamada, Kenji Kita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 11, 2023
Successful second-line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal-epithelial transition factor amplificationMakoto Yamamoto, Takeshi Terashima, Tatsuya Yamashita, et al.
Cancer Research|November 11, 2010
Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivoShinji Takeuchi, Akiko Takahashi, Noriko Motoi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutationJunya Nakade, Shinji Takeuchi, Takayuki Nakagawa, et al.
Pancreas|July 19, 2014
Expression of Akt kinase-interacting protein 1, a scaffold protein of the PI3K/PDK1/Akt pathway, in pancreatic cancerKoushiro Ohtsubo, Tadaaki Yamada, Lu Zhao, et al.
Pageof 12